These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6609429)

  • 1. Use of activated clotting time to monitor anticoagulation during cardiac surgery.
    Niinikoski J; Laato M; Laaksonen V; Jalonen J; Inberg MV
    Scand J Thorac Cardiovasc Surg; 1984; 18(1):57-61. PubMed ID: 6609429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery.
    Hendrice C; Schmartz D; Pradier O; Coron T; Kucharcezwski C; d'Hollander A; Capel P
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):245-9. PubMed ID: 7545449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation.
    Ottesen S; Stormorken H; Hatteland K
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):123-8. PubMed ID: 6611586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique.
    Preiss DU; Schmidt-Bleibtreu H; Berguson P; Metz G
    Klin Wochenschr; 1985 Mar; 63(6):252-6. PubMed ID: 3872962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two methods for heparin monitoring: a semi-automated heparin monitoring device and activated clotting time during extracorporeal circulation.
    Stead SW
    Int J Clin Monit Comput; 1989 Dec; 6(4):247-54. PubMed ID: 2628513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of activated coagulation time to monitor heparin during cardiac surgery.
    Roth JA; Cukingnan RA; Scott CR
    Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management.
    Hoenicka M; Rupp P; Müller-Eising K; Deininger S; Kunert A; Liebold A; Gorki H
    J Thromb Haemost; 2015 Jul; 13(7):1196-206. PubMed ID: 25954849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA; Lewis M
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 16. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
    Bauer A; Hausmann H; Schaarschmidt J; Szlapka M; Scharpenberg M; Eberle T; Hasenkam JM
    Thorac Cardiovasc Surg; 2019 Apr; 67(3):191-202. PubMed ID: 29290078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery.
    Abuelkasem E; Mazzeffi MA; Henderson RA; Wipfli C; Monroe A; Strauss ER; Chow JH; Tanaka KA
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2153-2160. PubMed ID: 30737123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system].
    Sakurada T; Kikuchi Y; Koushima R; Nakashima S; Hachiro Y; Kagaya H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):836-40. PubMed ID: 9217380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery.
    DeLaria GA; Tyner JJ; Hayes CL; Armstrong BW
    Arch Surg; 1994 Sep; 129(9):944-50; discussion 950-1. PubMed ID: 8080377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.